In this episode of The Psychedelic Skeptic, Dr. Anne Metz speaks with Dr. Daniel Moseley, Assistant Professor of Bioethics at East Carolina University's Brody School of Medicine. Dr. Moseley brings his unique background spanning philosophy and psychiatry to explore the ethical dimensions of psychedelics through the lens of human enhancement.
Episode Highlights:
- Dr. Moseley discusses his journey from philosophy to bioethics and his work on human enhancement for the Stanford Encyclopedia of Philosophy
- The distinction between therapeutic treatments versus enhancement uses of medical technologies
- How psychedelics differ from other enhancement technologies by affecting the whole person rather than specific capacities
- The ethical debates around personal freedom versus paternalism in regulating enhancement technologies
- Exploration of ego dissolution experiences and different philosophical interpretations
- Discussion of the current challenges in psychedelic research, including placebo effects and exogenous factors
- Concerns about how political and healthcare system changes might impact psychedelic therapies
Resources Mentioned:
- Jonathan Lear's work on the parallels between ancient Greek ethics and psychotherapy, particularly his book "The Concept of Irony"
- Peter Kramer's book "Listening to Prozac"
Follow Dr. Daniel Moseley's work at danieldmoseley.com and his blog "Dispatches from the Blood-Brain Barrier."
The Psychedelic Skeptic is available on all major podcast platforms. For more information visit annemetz.com or follow @doctormetz on Instagram. Have a question or guest suggestion? Email hello@annemetz.com.
